allulose stimulates glp 1 Peroral D-allulose suppresses food intake and releases GLP-1 in normal Allulose is a rare monosaccharide

The results are clinically significant

Widely used for type 2 diabetes mellitus and obesity, GLP-1RAs may increase risk for injection-site reactions.

Many people across the country have turned to Wegovy (semaglutide) to help manage their type 2 diabetes and lose excess weight

Starting July 1, 2026, the Centers for Medicare and Medicaid Services (CMS) will launch a new federal program that gives many Medicare beneficiaries access to GLP-1 medications for weight management []

Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as breakthrough drugsin 2023 and their popularity has soared since. More than 4 million items of tirzepatide and semaglutide were dispensed on the NHS in England in 2025/20261, while around2.5 million people each monthaccessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of []

Disposal is often free or low-cost: Many US pharmacies accept sharps containers for disposal